Clinical Trial Update: Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports completion and posting of results for a Phase I/II study of fludarabine plus busulfan with allogeneic progenitor cell support…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Malignancies

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematologic Malignancies | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2012-02-28